Exploring the Therapeutic Potential of Entheogens in Postoperative Cognitive Decline and Psychological Resilience.
ACS Med Chem Lett
; 15(9): 1437-1439, 2024 Sep 12.
Article
en En
| MEDLINE
| ID: mdl-39291007
ABSTRACT
Recent advancements in medical research have focused on the utilization of entheogens, particularly psilocybin and its related compounds, as therapeutic agents in mitigating cognitive decline and enhancing psychological resilience in patients undergoing anesthesia and sedation. This Patent Highlight integrates findings from three patent applications, each contributing unique insights into the potential applications of these substances in medical settings. The article examines the therapeutic mechanisms, proposed treatment methods, and potential clinical outcomes, offering an overview of this innovative approach to postoperative care.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
ACS Med Chem Lett
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos